Learn about metabolic syndrome, its causes, symptoms, and ways to manage it. Discover how lifestyle changes and treatments ...

As the number of metabolic syndrome components increased, the risks for all-cause and vascular dementias linearly increased. Metabolic syndrome is associated with worse cognitive performance and ...

New research indicates that people with cardiovascular-kidney-metabolic syndrome may have a higher risk of developing ...

People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...

Obesity has become a global epidemic affecting diverse populations and leading to metabolic syndrome across different sexes ...

Weight gain, particularly abdominal obesity, significantly impacts individuals with metabolic syndrome. It exacerbates ...

REL-P11 is a proprietary, low-dose, modified-release psilocybin formulation. Single-Ascending Dosing (SAD) study to evaluate safety and pharmacokinetics in obese and normal weight ...

Studies have suggested that in urban Indian populations, the age-adjusted prevalence of metabolic syndrome - a cluster of conditions including abdominal obesity, high blood pressure, impaired fasting ...

Relmada Therapeutics (RLMD) announced the initiation of dosing in a Phase 1 SAD study of REL-P11, an investigational agent for metabolic ...

NYC Health + Hospitals/Queens held a ribbon-cutting ceremony last month to celebrate the launch of its new Weight Management ...